top of page
Untitled design - 2025-11-13T041012.350.png

/ CAPABILITIES AND EXPERTISE /

End-to-End (E2E) Real World Evidence (RWE) Solutions

We collaborate with clients to strategize and develop Real World Evidence (RWE) studies that characterize unmet needs of disease, quantify clinical and economic burden of disease, estimate the effects of covariates on clinical and economic outcomes using a range of statistical programming packages, and multivariable and multivariate statistical models.

In particular, we help clients conceptualize and refine “What”, “Why”, “How”, “When”, and anticipated impact of RWE studies from fit-for-purpose Real World Data (RWD) identification, study protocol development and reviews, analytics requirements and specifications (e.g., SAP, PRS, TLFs), study implementation, application of appropriate econometrics/statistics methods, programming and analytic dataset construction, analysis and reporting, interpretation of results, and creation of dissemination materials (e.g., study report, abstracts, posters, manuscript). 

RWE Study Types
  • Disease Incidence and Prevalence

  • Disease Risk Scores

  • Patients’ Characteristics (e.g., Demographic, Clinical, Lifestyle, Geographic, Socioeconomic)

  • Target Sub-Population

  • Treatment Patterns

  • Therapeutic Burden & Medication Adherence

  • Burden of Disease/Illness

  • Cost of Disease/Illness

  • Disease and Treatment Outcomes

  • Health Care Resource Utilization (HCRU)

  • Costs associated with HCRU (Direct and Indirect)

  • Social Determinants of Health and Health Care Analysis

  • Comparative Effectiveness Analysis

  • Healthcare Policy Impact Analysis (e.g., Equity, Access, HCRU, Cost, Health Outcomes)

  • Input Parameters Generation for Decision Analytic/Health Economic (HE) modelling

bottom of page